ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
L65-293,Rabeprazole,CYP2C19,"Minor â€“ result should be considered as may affect medicationresponse"
L65-293,Quetiapine,CYP3A4,Usual prescribing considerations apply
L65-293,Timolol (component of Azarga),CYP2D6,Usual prescribing considerations apply
L65-293,fluorometholone,NA,NO
L65-293, brimonidine,NA,NO
L65-293, brinzolamide (component of Azarga),NA,NO
